Author

Anoushka Kathiravan

University of California, Los Angeles

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Angeliki Diotima IoannidisiD· 2 shared Frank PajonkiD· 2 shared Ling HeiD· 2 shared Purva JoshiiD· 2 shared Carter J. HoffmaniD· 1 shared Evelyn ArambulaiD· 1 shared Harley I. KornblumiD· 1 shared Julian P. WhiteleggeiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Angeliki Diotima IoannidisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Repurposing Quetiapine as an Adjuvant Therapeutic Agent for Triple-Negative Breast Cancer

Ling He, Purva Joshi, Angeliki Diotima Ioannidis, Anoushka Kathiravan, Mohammad Saki, Frank Pajonk

This study evaluates quetiapine as an adjuvant therapy for triple-negative breast cancer, showing it reduces clonogenicity, promotes apoptosis, and impairs DNA repair and migration.

Radiation Research · Apr 23, 2026Peer-reviewedCancer Biology

Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1

Ling He, Angeliki Diotima Ioannidis, Evelyn Arambula, Carter J. Hoffman, Purva Joshi, Anoushka Kathiravan, Julian P. Whitelegge, Linda M. Liau, Harley I. Kornblum, Frank Pajonk

This study shows that activation of the mevalonate pathway and Rac-1 in glioblastoma cells after anti-cancer treatments promotes recurrence, and statins combined with radiation improve survival in mouse models.

Cancer Research Communications · Jun 5, 2024Peer-reviewedNeuroscience